Home LiteratureArticle Details
PMID: 67209 Published · ppublish English Journal Article

Lysis of human normal and sarcoma cells in tissue culture by normal human serum: implications for experiments in human tumor immunology.

Journal of the National Cancer Institute ·Vol. 58 ·No. 5 ·1977-05-00 ·Pages 1233-8

Rosenberg SA

Abstract

Sera from 8 of 9 patients with osteogenic sarcoma equally lysed autologous tissue-cultured cells of both skin and osteosarcoma in the presence of complement. Of 155 normal human sera tested, 103 (66%) lysed allogeneic normal ksin in tissue culture. These antibodies appeared more prevalent in younger (96% in ages 11-20 yr) than older (33% in ages 41-50 yr) humans. The presence of these "natural" antibodies against normal and malignant cells growing in tissue culture was possibly directed against components adsorbed to the cells during tissue culture or to "new" cell-surface antigens expressed by these cells grown in tissue culture. These non-tumor-related neoantigens on normal and malignant cells in tissue culture represented a potential source of confusion in studies of the serologic response of humans to tumors.

MeSH Terms
Adolescent Adult Age Factors Antibodies Antibodies, Neoplasm Child Complement System Proteins Culture Media Culture Techniques Cytotoxicity Tests, Immunologic Epitopes Humans Middle Aged Osteosarcoma/immunology Skin/immunology
Chemicals
Antibodies Antibodies, Neoplasm Culture Media Epitopes Complement System Proteins
Authors & Affiliations
1 authors, click to expand affiliations / ORCID
Rosenberg S A
Article Info
Journal
Journal of the National Cancer Institute
Abbr.
J Natl Cancer Inst
ISSN
0027-8874
Published
1977-05-00
Pages
1233-8
Language
English
Region
United States
NLM ID
7503089
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]